Expert Opinion on Pharmacotherapy

Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy
pp. 3137-3144(8)
Authors: Cai, Qingqing; Huang, Huiqiang; Sun, Xiaofei; Xia, Zhongjun; Li, Yuhong; Lin, Xubin; Guo, Ying

Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial
pp. 3145-3149(5)
Authors: Mazza, Marianna; Squillacioti, Maria Rosaria; Pecora, Riccardo Daniele; Janiri, Luigi; Bria, Pietro

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia
pp. 3151-3158(8)
Authors: Nakou, ES; Filippatos, TD; Kiortsis, DN; Derdemezis, CS; Tselepis, AD; Mikhailidis, DP; Elisaf, MS

The pharmacological treatment of depression in adults with epilepsy
pp. 3159-3168(10)
Authors: Mula, Marco; Schmitz, Bettina; Sander, Josemir W

Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers
pp. 3169-3177(9)
Authors: Devi, P Uma; Manocha, Anshu; Vohora, Divya

Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients
pp. 3179-3196(18)
Authors: Filioti, Ioanna; Iosifidis, Elias; Roilides, Emmanuel

Treatment options for esophageal cancer
pp. 3197-3210(14)
Authors: Murphy, Thomas J; Ravi, Narayamasamy; Reynolds, John V

Treatment strategies for Behçet's disease
pp. 3211-3219(9)
Authors: Fresko, Izzet; Yazici, Hasan

Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease
pp. 3221-3230(10)
Authors: Kelly, Clive; Saravanan, Vadivelu

Developing clinical role of a CCR5 co-receptor antagonist in HIV-1 infection
pp. 3231-3242(12)
Authors: Caldwell, David J; Evans, Jeffery D

Taribavirin for the treatment of chronic hepatitis C
pp. 3243-3249(7)
Authors: Kearney, Keith R; Thornton, James J; Navarro, Victor J

Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders
pp. 3251-3259(9)
Authors: Abbas, Atheir; Roth, Bryan L

Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting
pp. 3261-3270(10)
Authors: Van Belle, Simon JP; Cocquyt, Veronique

Inhaled corticosteroids in COPD: systemic effects of a local therapy?
pp. 3271-3273(3)
Author: Antoniu, Sabina A